Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Templin

Showing results (261-270 of 293) with videos related to

Pageof 30
Sort By:
European Heart Journal. Digital Health|May 21, 2025
Machine-learning phenotyping of patients with functional mitral regurgitation undergoing transcatheter edge-to-edge repair: the MITRA-AI studyFabrizio D'Ascenzo, Filippo Angelini, Corrado Pancotti, et al.
Revista Espanola De Cardiologia (English Ed.)|July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary SyndromeSergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
International Journal of Cardiology|April 12, 2019
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life)Carloalberto Biolè, Zenon Huczek, Ivan Nuñez-Gil, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 10, 2025
Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary interventionPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2026
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trialMiklos Rohla, Kurt Huber, Ferdinando Varbella, et al.
The New England Journal of Medicine|August 27, 2023
Timing of Complete Revascularization with Multivessel PCI for Myocardial InfarctionBarbara E Stähli, Ferdinando Varbella, Axel Linke, et al.
Scientific Reports|June 26, 2026
Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMIPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Thrombosis Research|June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registryCarme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.
International Journal of Cardiology|December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelorMatteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
Pageof 30

Showing results (261-270 of 293) with videos related to

Sort By:
Pageof 30
European Heart Journal. Digital Health|May 21, 2025
Machine-learning phenotyping of patients with functional mitral regurgitation undergoing transcatheter edge-to-edge repair: the MITRA-AI studyFabrizio D'Ascenzo, Filippo Angelini, Corrado Pancotti, et al.
Revista Espanola De Cardiologia (English Ed.)|July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary SyndromeSergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
International Journal of Cardiology|April 12, 2019
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life)Carloalberto Biolè, Zenon Huczek, Ivan Nuñez-Gil, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 10, 2025
Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary interventionPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2026
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trialMiklos Rohla, Kurt Huber, Ferdinando Varbella, et al.
The New England Journal of Medicine|August 27, 2023
Timing of Complete Revascularization with Multivessel PCI for Myocardial InfarctionBarbara E Stähli, Ferdinando Varbella, Axel Linke, et al.
Scientific Reports|June 26, 2026
Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMIPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Thrombosis Research|June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registryCarme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.
International Journal of Cardiology|December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelorMatteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
Pageof 30